BeCertain, a UK-based AI-powered dental diagnostics platform, has raised £1.7 million ($2.3 million) in pre-seed funding led by Sure Valley Ventures. The platform analyzes 2D intraoral X-rays with proprietary uncertainty-aware machine learning that provides calibrated confidence levels for every detection, reducing diagnostic error rates that currently exceed 50% in dental practices. The capital will drive product development and commercialization.
Dental AI Market Draws Specialized Investors
The timing aligns with growing interest in clinical AI for dentistry. Overjet raised substantial funding reaching $174 million total, while Pearl secured $91.3 million in its Series B. BeCertain's approach of delivering confidence scores alongside detections addresses the trust gap that limits adoption of black-box systems from larger competitors.
Diagnostic Errors Exceed 50% in X-Ray Reads
Around 20 million dental X-rays are taken annually in the UK alone, yet diagnostic error rates surpass 50% for certain findings. This inconsistency leads to missed diseases, increased litigation risk, and clinician burnout. Existing solutions often issue binary outputs without indicating reliability, leaving dentists to second-guess results in ambiguous cases.
Uncertainty Quantification Builds Clinical Trust
BeCertain's system detects pathologies such as tooth decay, bone loss, and infections on 2D X-rays while reporting how certain the model is in each assessment. This differs from competitors that provide deterministic detections without calibration. The platform also generates automated draft reports and integrates with existing practice management software.
"The hard part in clinical AI isn't detection, it's trust. That's what we've built: a system that tells clinicians how confident it is rather than issuing a black-box verdict."
Sure Valley Ventures Leads with AI Focus
Sure Valley Ventures led the round, drawing on its experience backing AI software companies including CameraMatics and Landvault. Innovate UK participated through its Investor Partnership Growth Catalyst programme, adding government validation for a university spinout from King's College London and University of Surrey. The combination signals strong institutional support for regulated healthtech AI.
Market Expands from $559M to $3.26B
The AI dental software market stands at $559 million in 2025 and is projected to reach $3.26 billion by 2034, growing at 21.8% CAGR. Competitors such as VideaHealth (~$60 million raised), Denti.AI ($2.36 million), and Diagnocat ($1.82 million) illustrate varying funding levels across the space. Structural drivers include regulatory pathways for Software as a Medical Device and demand for explainable AI in clinical settings.
Academic Pedigree Strengthens Positioning
Co-founder and CEO Dr. Yunpeng Li serves as Reader in AI & Digital Oral Health at King's College London, while Co-founder and CMO Professor Owen Addison brings frontline clinical expertise. The company originated from research at both King's and the University of Surrey, backed initially by a £1.75 million NIHR i4i Product Development Award.